Literature DB >> 16554999

Hepatocellular carcinoma arising from nonalcoholic steatohepatitis: report of two cases.

Seikan Hai1, Shoji Kubo, Taichi Shuto, Hiromu Tanaka, Shigekazu Takemura, Takatsugu Yamamoto, Akishige Kanazawa, Masao Ogawa, Kazuhiro Hirohashi, Kenichi Wakasa.   

Abstract

Sporadic cases of hepatocellular carcinoma (HCC) originating from nonalcoholic steatohepatitis (NASH) have recently been reported. Thus, we investigated the prevalence of NASH in patients with HCC. A review of the clinical records of 481 patients who underwent liver resection for HCC in our department between January 1991 and December 2003 revealed only two (0.4%) patients with HCC associated with NASH. Both of these patients had noninsulin-dependent diabetes mellitus, and neither had a history of alcohol consumption or blood transfusion. All serologic markers for hepatitis B and C viruses were negative. Histological examination of the noncancerous hepatic tissue revealed NASH with moderate hepatic fibrosis in one patient and cirrhosis in the other. Thus, clinical follow-up and screening for HCC should be done for patients with hepatic fibrosis caused by NASH, even though this form of hepatitis is an uncommon cause of HCC.

Entities:  

Mesh:

Year:  2006        PMID: 16554999     DOI: 10.1007/s00595-005-3167-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  24 in total

1.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

Authors:  Elisabetta Bugianesi; Nicola Leone; Ester Vanni; Giulio Marchesini; Franco Brunello; Patrizia Carucci; Alessandro Musso; Paolo De Paolis; Lorenzo Capussotti; Mauro Salizzoni; Mario Rizzetto
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

Review 2.  Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss.

Authors:  F H Luyckx; P J Lefebvre; A J Scheen
Journal:  Diabetes Metab       Date:  2000-04       Impact factor: 6.041

3.  Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus.

Authors:  H Orikasa; R Ohyama; N Tsuka; B P Eyden; K Yamazaki
Journal:  J Submicrosc Cytol Pathol       Date:  2001 Jan-Apr

4.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

5.  Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma.

Authors:  S Kubo; K Hirohashi; H Tanaka; T Tsukamoto; T Shuto; T Ikebe; T Yamamoto; K Wakasa; S Nishiguchi; T Kuroki; H Kinoshita
Journal:  World J Surg       Date:  2000-12       Impact factor: 3.352

Review 6.  Nonalcoholic steatohepatitis.

Authors:  A E Reid
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

7.  Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma.

Authors:  S Kubo; K Hirohashi; H Tanaka; T Tsukamoto; T Shuto; T Yamamoto; T Ikebe; K Wakasa; S Nishiguchi; H Kinoshita
Journal:  Cancer       Date:  2000-03-01       Impact factor: 6.860

Review 8.  Nonalcoholic steatohepatitis.

Authors:  B A Neuschwander-Tetri; B R Bacon
Journal:  Med Clin North Am       Date:  1996-09       Impact factor: 5.456

9.  Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.

Authors:  Y Zen; K Katayanagi; K Tsuneyama; K Harada; I Araki; Y Nakanuma
Journal:  Pathol Int       Date:  2001-02       Impact factor: 2.534

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  8 in total

1.  Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease.

Authors:  Toshifumi Wakai; Yoshio Shirai; Jun Sakata; Pavel Vladimirovich Korita; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

Review 2.  Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review.

Authors:  Yoshitaka Takuma; Kazuhiro Nouso
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

3.  Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list.

Authors:  Metin Basaranoglu; Sonia M Najjar; Ali Ebag Demirbag; Hakan Senturk
Journal:  World J Hepatol       Date:  2016-03-08

4.  Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis.

Authors:  Hirokazu Kawai; Minoru Nomoto; Takeshi Suda; Kenya Kamimura; Atsunori Tsuchiya; Yasushi Tamura; Masahiko Yano; Masaaki Takamura; Masato Igarashi; Toshifumi Wakai; Satoshi Yamagiwa; Yasunobu Matsuda; Shogo Ohkoshi; Isao Kurosaki; Yoshio Shirai; Masahiko Okada; Yutaka Aoyagi
Journal:  World J Hepatol       Date:  2011-01-27

5.  The association of nonalcoholic steatohepatitis and hepatocellular carcinoma.

Authors:  Mohammad Maysara Asfari; Muhammad Talal Sarmini; Mohammad Alomari; Rocio Lopez; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-12       Impact factor: 2.586

Review 6.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.

Authors:  Donna L White; Fasiha Kanwal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-04       Impact factor: 11.382

Review 7.  [Hepatocellular carcinoma in the non-cirrhotic liver].

Authors:  M Evert; F Dombrowski
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

Review 8.  Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics.

Authors:  Renumathy Dhanasekaran; Alpna Limaye; Roniel Cabrera
Journal:  Hepat Med       Date:  2012-05-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.